Gujarat Terce Laboratories (BOM:524314) COGS-to-Revenue : 0.32 (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Gujarat Terce Laboratories COGS-to-Revenue?

Gujarat Terce Laboratories's Cost of Goods Sold for the three months ended in Dec. 2023 was ₹42.3 Mil. Its Revenue for the three months ended in Dec. 2023 was ₹130.2 Mil.

Gujarat Terce Laboratories's COGS to Revenue for the three months ended in Dec. 2023 was 0.32.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Gujarat Terce Laboratories's Gross Margin % for the three months ended in Dec. 2023 was 67.54%.

Gujarat Terce Laboratories COGS-to-Revenue Historical Data

The historical data trend for Gujarat Terce Laboratories's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Terce Laboratories COGS-to-Revenue Chart

Gujarat Terce Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

COGS-to-Revenue

Get a 7-Day Free Trial

0.39

0.37

0.41

0.39

0.42

Gujarat Terce Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.35	0.52	0.37	0.36	0.32

Gujarat Terce Laboratories COGS-to-Revenue Calculation

Gujarat Terce Laboratories's COGS to Revenue for the fiscal year that ended in Mar. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	197.627	/	467.825
	=	0.42

Gujarat Terce Laboratories's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	42.269	/	130.202
	=	0.32

Gujarat Terce Laboratories (BOM:524314) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Gujarat Terce Laboratories's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	42.269 / 130.202
	=	67.54 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Gujarat Terce Laboratories COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Gujarat Terce Laboratories's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Gujarat Terce Laboratories (BOM:524314) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Terce Laboratories Ltd (BOM:524314) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Near Shivalik High-Street,, D/801 & 802,The First,, Behind Keshavbaug Party Plot,, Vastrapur,, Ahmedabad, GJ, IND, 380015

Website

https://www.gujaratterce.in

Gujarat Terce Laboratories Ltd is an India company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, and syrup and injection. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, anti-fungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash , Aziter and others.

Gujarat Terce Laboratories (BOM:524314) Headlines

No Headlines